Non-invasive continuous hypoxia assessment in intra-partum fetus through long wavelength near infrared spectroscopy

Intra-partum hypoxia is the principal cause of death for every 2 in 10000 infants. Monitoring hypoxia during child-birth will not only prevent infant mortality, but also help prevent cerebral palsy in 10-20% of the surviving babies. Current monitoring techniques either use an indirect biomarker (heart-rate in cardiotocograph) or measure downstream biomarkers intermittently and invasively (fetal blood sampling). For complete fetal wellbeing monitoring, a continuous non-invasive assessment of multiple biomarkers is needed during birth. To address this gap we are developing a noninvasive, continuous sensor based on long wavelength near infrared (LW-NIR) spectroscopic technique for the detection of fetal hypoxia through multiple biomarkers. For specific hypoxia assessment we have identified key optical spectroscopy compatible biomarkers from a list of various biomarkers effected in the physiological processes leading to the development of hypoxia. The key biomarkers identified are – cytochrome-C oxidase, oxygenated and deoxygenated hemoglobin, lactate, pyruvate and pH in the connective tissue in presence of other interferences such as lipids, proteins and other sugars. To translate these biomarkers into a viable diffuse-reflectance probe we assessed the light-tissue interaction in the low-scattering, water-absorption dominated LW-NIR window of 1350-2500 nm using Monte Carlo photon migration model and experimentally verified the penetration depth achievable in fetal tissue phantom to ~0.5 mm, only targeting the capillary bed.